All news

Cann Group secures $11M Mildura site for new cannabis greenhouse

Leading cannabis producer and researcher Cann Group (ASX: CAN) has acquired a $10.75 million property in Mildura to construct a greenhouse for the cultivation of cannabis

CBD oil products promise miracle cures. But does science support the hype?

The buzz around cannabis products is understandable. But we simply don't know enough yet about possible benefits — or risks

Scarce retail weed shops means most Canadians still use blackmarket pot

Statistics Canada says that during 2018’s fourth quarter, consumer cannabis spending totalled $1.478 billion. Unfortunately, only 21 per cent of that went toward legal cannabis

2019 UIC Medicinal Cannabis Symposium

22nd-24th March, Tweed Heads NSW

Impact of medical cannabis on patients with cancer enrolled in Minnesota's medical cannabis program

Minnesota’s medical cannabis program is unique, in that it routinely collects patient-reported scores on symptoms. This article focuses on changes in symptom severity reported by patients with cancer during their first 4 months of program participation

Whoopi Goldberg talks cannabis: 'I think it's worth trying'

Whoopi Goldberg talks about cannabis products, her Whopi & Maya brand, and more

Medicinal cannabis requires further clinical research and educational support

Dr Mark Ware, Chief Medical Officer at Canopy Growth, provides an overview of the research that already exists around medicinal cannabis

Cannabis company hires billionaire snack food tycoon Nelson Peltz

Canadian company Aurora Cannabis said Wednesday it has hired snack-food tycoon Nelson Peltz as a strategic adviser

Medicinal cannabis users left high and dry by Dutch tolerance policy

Many patients find cannabis calms their symptoms, eases pain and reduces the side-effects of other medication – but despite the relaxed attitude to marijuana in the Netherlands, acquiring this alternative medicine is often a battle

Zelda strikes up partnership to break into US medicinal cannabis market

Zelda and Ilera Healthcare will explore a range of commercialisation opportunities to tap into the lucrative US medicinal cannabis market